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Abstract
Background—Conventional management for concussion involves prescribed rest and 
progressive return to activity. Recent evidence challenges this notion and suggests that active 
approaches may be effective for some patients. Previous concussion consensus statements provide 
limited guidance regarding active treatment.
Objective—To describe the current landscape of treatment for concussion and provide summary 
agreements related to treatment in order to assist clinicians in the treatment of concussion.
Methods—On October 14–16, 2015, the Targeted Evaluation & Active Management (TEAM) 
Approaches To Treating Concussion meeting was convened in Pittsburgh, Pennsylvania, USA. 37 
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concussion experts from neuropsychology, neurology, neurosurgery, sports medicine, physical 
medicine and rehabilitation, physical therapy, athletic training, and research, and 12 individuals 
representing sport, military, and public health organizations attended the meeting. The 37 experts 
indicated their agreement on a series of statements using an audience response system clicker 
device.
Results—A total of 16 statements of agreement were supported covering: 1) Summary of the 
Current Approach to Treating Concussion, 2) Heterogeneity and Evolving Clinical Profiles of 
Concussion, 3) Targeted Evaluation and Active Management Approach to Concussion Treatment: 
Specific Strategies, and 4) Future Directions: A Call to Research. Support (ie, response of agree or 
somewhat agree) for the statements ranged from to 97–100%.
Conclusion—Concussions are characterized by diverse symptoms and impairments and evolving 
clinical profiles; recovery varies based on modifying factors, injury severity, and treatments. 
Active and targeted treatments may enhance recovery following concussion. Research is needed 
on concussion clinical profiles, biomarkers, and the effectiveness and timing of treatments.
BACKGROUND
The Centers for Disease Control and Prevention (CDC) have labeled concussion a major 
public health issue due to acute and potential long term effects associated with this injury. 
Sport and recreation related concussions (SRC) in particular have increased in incidence, 
with approximately 1.6 to 3.8 million SRCs occurring every year in the U.S.1 Emergency 
department visits for SRC doubled between 1997 and 2007 for children 8 to 13 years and 
increased 200% for adolescents 14 to 19 years of age.2 Recent epidemiological studies 
document increases in the reported incidence rates for SRC at both college and high school 
levels.3 Knowledge about concussion has increased significantly over the past decade with 
respect to the definition of signs and symptoms,4 assessment approaches,5 risk factors,6–10 
and prognosis.11,12 However, the treatment and management of concussion has received 
little attention in the literature during this time period. This progression is a natural 
phenomenon in medicine, with the initial phase focusing largely on the definition of the 
condition and its identification/diagnosis, followed by a later focus on its treatment.13 The 
limited research related to treatment has focused on the effectiveness of prescribed cognitive 
and physical rest,14,15 Moreover, the approach to treating and managing concussion is 
largely a uniform approach based on a conceptual framework as a homogeneous injury.16 
This is surprising given that current consensus statements highlight the individualized nature 
of concussion.17 In short, many clinicians are treating patients with concussion much the 
same way today as they did a decade ago: using a rest based approach.
The notion of treating a concussion more actively than prescribed rest is also not recognized 
by the public. In fact, in a recent Harris Poll, a majority (71%) of over 2,000 U.S. adults 
surveyed did not recognize that concussions are treatable.18 In this same report, 1 in 3 adults 
reported that their child received no prescribed treatment following a concussion. Among 
those receiving treatment, the most commonly reported treatments were prescribed rest 
(51%), hydration (34%), and over the counter medicine (28%).18
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OBJECTIVES
The preceding findings underscore the need to better align clinical practice with emerging 
concussion research. To that end, a group of concussion experts was convened October 14–
16, 2015 in Pittsburgh, Pennsylvania to determine areas of agreement regarding the current 
state of concussion treatment. In the current paper, we present the results of this 2-day effort. 
This paper is designed to foster an understanding among clinicians, scientists, as well as lay 
people that concussion symptoms and impairment are treatable using more active and 
targeted approaches than prescribed rest alone. The agreement statements that emerged from 
this meeting may be useful in guiding the treatment of concussions that result from a variety 
of causes including sport and recreational activities, motor vehicle collisions, falls, assaults, 
and those occurring during military service. It is important to note that the focus of the 
current meeting, this paper, and concomitant statements was on agreement and not 
consensus, per se. In contrast to meetings such as the 4th International Conference on 
Concussion, which employed formal consensus meeting guidelines from the Consensus 
Development Program in the Office of Disease Prevention of the US National Institutes of 
Health (NIH)-which have since been retired by the NIH, the current meeting employed a 
majority voting approach to determining agreement on each statement. We employed a 
method of voting similar to that used by Smith and colleagues (see Methods section below 
for additional information).19
PURPOSE
The primary purpose of the current paper is to review the current state of treatment for 
concussion and provide summary agreements to assist clinicians in the treatment of this 
injury. Additional purposes of the paper are to: 1) summarize current expert consensus and 
empirical gaps in the research related to treating concussion; 2) present and describe clinical 
approaches to conceptualizing and classifying concussion; 3) discuss targeted evaluation and 
active management approaches for treating concussion; and 4) identify key areas regarding 
concussion treatment that require further research and support. For both the meeting and 
paper, the term concussion was defined per the 4th International Conference on 
Concussion.17 The current paper was intended to build on previous statements that provide 
guidelines for definitions, signs/symptoms, evaluation, return to play (RTP), and other issues 
related to concussion. The reader is therefore referred to the papers discussed later in this 
paper for additional information about these topics. The paper is organized into 4 primary 
sections that reflect the content of the presentations and focus of the meeting. The 4 sections 
include: 1) Summary of the Current Approach to Treating Concussion, 2) Heterogeneity and 
Evolving Clinical Profiles of Concussion, 3) Targeted Evaluation and Active Management 
Approach to Concussion Treatment: Specific Strategies, and 4) Future Directions: A Call to 
Research.
METHODS
For the reasons outlined above, on October 14–16, 2015, the Targeted Evaluation & Active 
Management (TEAM) Approaches To Treating Concussion meeting was convened in 
Pittsburgh, Pennsylvania, USA. The meeting was supported through grants from the 
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National Football League and University of Pittsburgh Medical Center. Neither organization 
influenced the content of the meeting or this paper. Concussion experts from 
neuropsychology, neurology, neurosurgery, sports medicine, physical medicine and 
rehabilitation, physical therapy, athletic training, and research (referred to as “authors” 
throughout this document); as well as individuals representing sports, the military, and 
public health organizations (referred to as “participants” throughout this document) attended 
the meeting. A total of 38 authors, representing 33 clinical and academic institutions, and 14 
participants, representing 12 sport, military, and public health organizations, attended the 
meeting. Prior to the meeting, the statements of agreement, along with supporting 
information and references, were drafted by the primary authors and circulated to 
contributing authors for review and comment. All primary authors, contributing authors, and 
invited participants were required to sign an International Committee of Medical Journal 
Editors (ICMJE) Form for Disclosure of Potential Conflicts of Interest. Detailed information 
related to each author’s affiliations and conflicts of interests are available in the Appendix.
Following an initial day of presentations by experts in the relevant areas and discussion of 
this paper with the author and participants, key statements of agreement were voted on, 
evaluated, and revised by the authors. During the month following the meeting, authors were 
assigned (by the primary authors based on expertise and meeting group assignments) in 
groups of 2–3 to develop 1–2 statements of agreement and subsequently revise a supporting 
section. After 2 rounds of revisions with authors, the primary authors edited and compiled a 
final paper that was then reviewed and approved by all primary and contributing authors.
Determining Agreement for Each Statement
Each of the authors was provided with an audience response system (ARS) clicker device to 
register their agreement level with each statement. Invited participants, though active in the 
meeting and discussions of each statement of agreement, were not provided with ARS 
devices in order to avoid conflicts with their positions within their representative 
organizations. The ARS devices were tested prior to each session to make sure they were 
working correctly. Following topical presentations and a panel discussion related to each 
statement of agreement, authors indicated their agreement with each statement using a 1-
disagree, 2-somewhat disagree, 3-somewhat agree, or 4-agree point Likert-type response 
scale. All statements of agreement for a particular section were voted on prior to revealing 
the results to the audience. All votes were anonymous and a summary of group response 
data for each item was provided to all authors and invited participants immediately 
following the conclusion of voting in each section. The authors and invited participants 
discussed each statement of agreement and vote in an open forum. During these open forum 
discussions, authors were able to propose new statements of agreement for consideration. At 
this time, statements were revised based on suggestions and feedback from the authors and 
invited participants. These revisions and any newly proposed statements were discussed 
further during breakout sessions that included authors representing each of the sections of 
the paper (see section author list). Statements that received greater than 50% combined 
“disagree” and “somewhat disagree” ratings or those that were unclear were revised for a 
second vote. However, voting results indicated that none of the statements of agreement met 
the preceding criteria. The voting sessions were open only to authors. Subsequent to all 
Collins et al. Page 5
Neurosurgery. Author manuscript; available in PMC 2017 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
revisions as agreed upon by the authors from each session, all statements of agreement were 
subject to an additional round of voting on the second day of the meeting. Any authors who 
had to leave the meeting prior to this second round of voting were allowed to submit an 
absentee vote via email. It is important to note that for 12 of 16 (75%) statements of 
agreement, a 100% response rate was attained. However, 1 (2.7%) author abstained from 
voting for statements 9 and 11, and 2 (5.4%) authors abstained from voting for statements 10 
and 12, resulting in a response rate of 94.6% to 97.3%. A summary of the final voting results 
for each statement of agreement is provided in Table 1. Voting results for the Future 
Directions statements of agreement are presented later in the paper. None of the authors 
abstained from voting on any of the Future Directions statements of agreement, resulting in 
a 100% response rate.
SUMMARY OF THE CURRENT APPROACH TO TREATING CONCUSSIONS
1 Prior expert consensus for management of concussion included: a) no same-
day return to play, b) prescribed physical and cognitive rest until 
asymptomatic, c) accommodations at school/work as needed, and d) 
progressive aerobic exertion-based RTP based on symptoms.
2 Previous consensus statements have provided limited guidance with regard to 
the active treatment of concussion.
Current concussion consensus statements advocate for concussion management strategies 
including: a) no RTP or activity for individuals with a suspected concussion, b) prescribed 
cognitive and physical rest until asymptomatic, c) accommodations at school/work as 
needed, and d) progressive aerobic exertion-based RTP or activity based on 
symptoms.17,20–23 A majority of athletes respond well to this management approach and 
have a favorable return to full activity. However, some individuals experience persistent 
symptoms that do not respond to these conventional management strategies.
Most concussion consensus documents have focused on SRC. A summary of statements 
regarding management of concussion from each of these sport-specific consensus documents 
is provided in Table 2. Although some of these statements mention that there may be other 
symptom-based approaches to treating concussion, they provide little in the way of specific, 
targeted treatment strategies or guidance with respect to the process of active treatment 
across recovery. The majority of current consensus statements endorse an approach to 
managing concussion (ie, prescribed rest followed by progressive return to activity) that is 
dependent on spontaneous resolution of symptoms and impairments, rather than active 
treatment.17,20,22,23 The most active aspect of previous consensus statements pertains to the 
use of education strategies and medications, primarily in the sub-acute recovery phase, to 
help manage specific symptoms (eg, Broglio et al, 201420; Harmon et al, 201323). To date, 
the focus of consensus documents has not included emerging, active treatment strategies for 
concussion, resulting in a limited foundation for clinicians treating patients with this injury.
3 There is limited empirical evidence for the effectiveness of prescribed physical 
and cognitive rest – with no multisite RCT for prescribed rest following 
concussion.
Collins et al. Page 6
Neurosurgery. Author manuscript; available in PMC 2017 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Although the current concussion consensus and position statements suggest patients may 
benefit from an initial period of physical and cognitive rest,17,20,22,23,26 these 
recommendations have been formulated primarily from anecdotal evidence, as there have 
been few high-quality prospective studies conducted regarding the effectiveness of rest. 
Recommendations for physical rest, which suggest the phased RTP progression does not 
begin until the patient is asymptomatic or back to baseline symptoms at rest, are included in 
most RTP guidelines.17,20,22,23,26 Healthcare providers routinely use prescribed physical rest 
in a variety of clinical settings.27,28 In contrast, healthcare providers prescribe cognitive rest 
less frequently.29,30 In a survey of pediatric providers, cognitive rest was only included as a 
written recommendation for 11% of pediatric patients.30 Similarly, researchers reported that 
cognitive rest was not recommended to any patient seen in the emergency department prior 
to 2008 and was only recommended to 12% of patients in 2012.29
Evidence for physical and cognitive rest has been characterized in retrospective study 
designs of small samples of primarily male patients from a single practice15,31–34 resulting 
in equivocal findings. Researchers noted that patients with the highest and lowest levels of 
activity had worse outcomes31 and took longer to recover,32 suggesting that too much or too 
little physical and cognitive activity could be detrimental to recovery. In contrast, researchers 
have reported that a 1-week period of cognitive and physical rest decreased symptoms and 
increased cognitive scores in nearly 60% of patients even when employed several weeks or 
months following injury.33 Other researchers have reported no association between 
prescribed rest and decrease of symptoms34 or recovery time.14 Only 1 small RCT of 
cognitive and physical rest following concussion has been published.35 These researchers 
reported that 5 days of strict rest following injury resulted in longer symptom duration and 
higher number of symptoms compared to usual care recommendations. Collectively, the 
limited body of evidence appears to be equivocal, however, some studies suggest that that 
too little30,31 and too much32,34 physical and cognitive rest may delay recovery, whereas an 
initial brief period of rest may be beneficial. These findings, though preliminary, clearly 
underscore the need for prospective, multi-site RCTs to inform the use and timing of 
prescribed rest compared with active treatments following concussion.
4 Prescribed physical and cognitive rest may not be an effective strategy for all 
patients following concussion.
The theory underpinning prescribed rest following concussion has been based on 2 tenets: 1) 
rest decreases exposure to additional head impacts and thus decreases the risk of re-injury 
during a vulnerable post-injury period,36 and 2) physical and cognitive activity often 
exacerbate symptoms and associated impairments in the post-injury period, thereby 
prolonging recovery.37,38 However, it is important to note that avoiding contact during the 
vulnerable period following concussion and prescribed rest represent 2 separate strategies. 
As such, avoiding contact during this time is always recommended to avoid further head 
impacts. In contrast, although prescribed non-contact, sub-acute, physical rest and cognitive 
rest may exacerbate symptoms, they do not appear to worsen pathophysiological injury or 
cause additional injury.39 The use of prescribed rest to treat patients with concussion has 
been based largely on expert consensus opinion,17,20,21 Factors that optimize the effects of 
prescribed rest (eg, what type, how long, etc.) remain unclear. Anecdotally, athletes with 
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certain symptoms and impairment may tolerate increased early activity, while others may 
benefit from longer and more complete physical and cognitive rest during the acute post-
injury period (see numbers 8, 12, 13). Both early activity and rest approaches may aid 
recovery and result in favorable outcomes following concussion. However, there is increased 
concern that too much rest may have negative consequences for patients who are slow to 
recover.
The deleterious effects of prolonged rest in patients with chronic conditions are well 
documented in the literature and reported in several chronic conditions ranging from low 
back pain40,41 to brain injury.42 More than 30 years ago, Relander et al42 randomized adult 
patients admitted to the hospital from the emergency department with mTBI to bed-rest 
versus active therapy and reported that subjects in the active therapy group were able to 
return to work 14 days earlier than the bed-rest group. Relander et al42 concluded that this 
active treatment was better for patients “who had exaggerated fears about their condition.” 
More recently, de Kruijk et al43 compared 6 days of bed rest versus no bed rest in a 
randomized clinical study of bed rest for treatment of concussion and showed no benefit to 
rest.43 In a retrospective study, Majerske et al31 reported that patients who reported low 
levels of post-injury physical and cognitive activity in the first month following injury had 
negative outcomes, whereas patients who reported moderate activity had the best outcomes 
at follow-up.31 Thomas et al35 randomized adolescents discharged with mTBI to 5 days 
prescribed physical and cognitive rest versus usual care and found that early, prolonged rest 
recommendations were associated with delayed recovery and more daily post-concussive 
symptoms, specifically, more physical symptoms early in recovery and emotional symptoms 
throughout recovery.35 In this study, researchers also reported that patients diagnosed with 
mTBI based on post-concussive symptoms alone and patients with a past history of 
concussion were more likely to have negative outcomes when randomized to 5 days of 
prescribed physical and cognitive rest. This study informs future research efforts to 
determine how rest may influence other subgroups of concussed patients. In addition, these 
data are supported in basic TBI neuroscience studies that document increased blood flow, 
brain growth factors, and synaptic plasticity following subacute physical (eg, running) and 
cognitive activity (enriched environment).44,45
The efficacy and utility of prescribed rest is challenged in the literature. Prescribed rest may 
exert a negative influence through hypervigilance on symptoms, preoccupation with ordered 
restrictions, reinforcement of negative expectations, social isolation, and removal from 
patients’ normal routines.46–48 For some patients, prescribed physical and cognitive rest may 
contribute to an increased symptom burden and prolonged recovery and therefore alternative 
(ie, more active) acute treatment paradigms should be considered.
5 Strict brain rest (eg, stimulus deprivation, “cocoon” therapy) is not indicated 
and may have detrimental effects on patients following concussion.
“Cocoon therapy” or “strict brain rest” refers to avoidance of all visual, auditory, light, 
social, intellectual, or physical exertion/stimulation.49 Although it is generally agreed that 
most concussed patients benefit from some form of initial physical and cognitive rest, 
prolonged strict brain rest can lead to social isolation, anxiety, and problems with self-
esteem, and potential loss of academic standing in students.50 Additional adverse effects of a 
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strict brain rest protocol include anxiety and depression, “nocebo” effect contributing to the 
exacerbation of symptoms, physical deconditioning, school delays, and other academic 
problems related to accumulating work load. Strict brain rest may also result in a cycle of 
symptoms resulting from prolonged periods of rest due to the self-perpetuation of symptoms 
in the context of strict brain rest.51 It is also important to note that individualized physical 
and cognitive activity restriction does not equate to strict brain rest. In conclusion, strict 
brain rest involving avoidance of nearly all brain stimulation is not empirically supported 
following concussion and may have unintended adverse effects on patients with this injury.
6 Although most individuals follow a rapid course of recovery over several days 
to weeks following injury, concussions may involve varying lengths of 
recovery.
It has been generally accepted that patients with concussions recover within 7 to 14 days 
following injury.17,21 However, there is an increasing number of studies that suggest 
concussion recovery may take longer for some patients and is influenced by demographic 
modifying factors including age (< 18 years),52–54 sex (female),53,55 and history of 
concussion (>2).53,56–59 Furthermore, concussions are heterogeneous, with varying levels of 
severity as well as injury-related modifying factors (eg, on-field dizziness, post-traumatic 
migraine) that may affect recovery (see number 7). In short, some patients report symptom 
recovery within a few days, while others report symptom recovery over a period of months 
to years.60
Previous research documenting concussion recovery has typically included a homogeneous 
demographic group, such as male football players, and focused on recovery as measured by 
symptoms and cognitive performance. As a result, the generalizability of previous findings 
to the wider community of athletes as well as individuals with non sport-related concussions 
may be limited. Studies of recovery time following concussion have incorporated varying 
definitions of recovery including symptom resolution,9,32,34 date of medical clearance 
(NCAA concussion guidelines), return to baseline performance,53,61–65 and statistical 
recovery.54,66,67 Moreover, there has been considerable variability in the observed length of 
recovery across studies depending on which criteria or assessment approaches were used to 
determine recovery. Concussion recovery appears to resolve within 7 days when brief acute 
assessments of cognition and postural stability are used (eg, Balance Error Scoring System 
[BESS], Standardized Assessment of Concussion [SAC])64,65,68–71 and assessments using 
symptom reports reveal an interval of recovery from 5 days64,65,69,72,73 to 14 days.74–77 
Cognitive recovery is even more variable with recovery reported between 764,65,69,70,78 and 
21 days.61,75,79 Meta-analytic reviews suggest that neurocognitive deficits persist beyond 14 
days across studies.68 However, an earlier meta-analysis supported a 7-day time period for 
these same deficits.80 On an individual basis, factors including litigation, worker’s 
compensation, and the population affected (eg, sport, military, civilian) may influence 
differences in these and other concussion-related outcomes. Recently, researchers have 
reported that when using comprehensive assessment approaches that include symptoms, 
cognitive, and vestibular-oculomotor reports, concussion recovery may extend up to 21–28 
days in high school and college-aged athletes.66 The findings from this study also indicate 
that concussion recovery may be domain-specific (ie, cognitive recovery persists longer than 
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self-reported symptoms and vestibular/oculomotor assessment) and are influenced by certain 
modifying factors such as sex (ie, females demonstrate a longer recovery). Although the 
majority of studies utilize common clinical tools that assess a variety of domains to 
determine recovery, recent neuroimaging studies report persistent findings in concussed 
patients that may reflect even longer recovery times.81–83 In summary, these findings 
suggest that recovery following concussion may vary considerably depending on the 
variables used to identify recovery and the populations that are being examined.
7 Recovery from concussion is influenced by modifying factors, the severity of 
injury, and the type and timing of treatment that is applied.
Consensus statements17,20–23,84 and researchers suggest that demographic and injury-related 
modifying factors, and the type and timing of certain treatments can influence concussion 
recovery.14,51,85 The frequency, severity, and recovery from concussion are influenced by 
demographic (eg, age (< 18 years old),53,54 sex (female),53,86–88 concussion history,58,89–93 
and premorbid factors including migraine,94 depression,95 anxiety,96 learning disability,78 
hyperactivity disorders,97 sleep disturbance,55,98 and overall symptom burden.99 In addition, 
factors related to symptom severity have been associated with prolonged recovery including 
post-traumatic amnesia (PTA),9,100 loss of consciousness (LOC),101 on-field dizziness,102 
post-traumatic migraine,11,103,104 acute symptom burden,69,77,105,106 and neurocognitive 
impairment.75,76 The severity of biomechanical forces and/or trauma is associated with 
prolonged recovery in mTBI patients in both civilian84 and military107 populations, however 
this relationship in sport and recreation populations is tenuous due to a limited number of 
studies and the difficulty in reliably connecting biomechanical impacts to concussion 
diagnosis and recovery outcomes.108–112 The type and timing of concussion treatments (eg, 
educational, behavioral, ocular-motor, vestibular, physical, and pharmacological) may 
expedite recovery,85,113 however if not executed properly, may unintentionally prolong 
recovery.14,31,35 For example, prescribed cognitive and physical rest is recommended in 
consensus statements as the initial treatment approach for concussion17,20–23 however these 
statements provide very little guidance on the timing and type of rest.
In summary, concussions are highly individualized injuries due in part to the effects of 
modifying factors, the severity of the injury, the type and timing of treatment, socio-cultural 
factors, and the clinical symptoms and diverse functional impairments exhibited by the 
patient. Clinicians should consider these factors when evaluating concussions, educating the 
patient, family, teachers and employers, and devising and implementing an active treatment 
approach to concussion care.
Heterogeneity and Evolving Clinical Profiles of Concussion
8 Concussions are characterized by diverse symptoms and impairments in 
function resulting in different clinical profiles and recovery trajectories.
As discussed in previous sections, concussions are heterogeneous and characterized by 
varied symptom presentation, which calls into question the general recommendation that all 
concussion patients be prescribed physical and cognitive rest until they are asymptomatic. 
Recently, clinical researchers have attempted to characterize or classify concussion into 
specific clinical profiles.114,115 Collins and colleagues114 categorized concussions into 6 
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clinical profiles including: 1) vestibular, 2) ocular-motor, 3) cognitive/fatigue, 4) post-
traumatic migraine, 5) cervical, and 6) anxiety/mood. These clinical profiles can be applied 
in the first week following injury, are not mutually exclusive, and may overlap and involve 
primary, secondary, and tertiary profiles. Each concussion profile carries specific evaluation 
and treatment/rehabilitation recommendations. Ellis and colleagues115 proposed a 
conceptual framework with 3 main post-concussion disorders, 1) physiological, 2) vestibulo-
ocular, and 3) cervicogenic. In addition, these researchers describe 2 post-concussion 
modifying factors: post-traumatic mood disorders and migraine. In this model, a period of 3 
weeks is required before patients can be categorized and the determination requires 
evaluation of the patient’s clinical history and the physical and symptom-based response to 
exercise treadmill testing. Potential overlap among the 3 main concussion profiles is not 
discussed.115
Both models provide direction for treatment based on a heterogeneous injury classification 
system. The adoption of concussion profiles may align the management of SRCs with that of 
non-sport concussions. For example, guidelines from civilian and military mTBI have begun 
to address the heterogeneous nature of concussion. In 2009 the Veterans Administration and 
the Department of Defense recommended evaluation and individualized treatment based on 
the presentation of certain symptoms including post-traumatic headache, insomnia, cognitive 
dysfunction, and mood-related symptoms in service members with persistent symptoms 
beyond 7 days.116 In 2011 the Ontario Neurotrauma Foundation and the Canadian MTBI 
Consensus group both recommended a targeted evaluation and treatment of post-traumatic 
headache, insomnia, cognition, mood, balance, vision, and fatigue but only for those with 
symptoms persisting more than 3 months.117,118 The pediatric version of the ONF 
guidelines published in 2014 also included a targeted, subject-specific evaluation for patients 
with symptoms lasting more than 1 month.119
The identification of clinical profiles may prove useful by emphasizing the need for 
multidimensional assessment and developing treatment approaches that are targeted to 
symptom presentation and findings from clinical evaluation. However, care must be 
exercised to not minimize individualized approaches by attempting to place patients into 
rigid profiles as profiles often overlap. The use of clinical profiles to characterize symptoms 
and impairment provides the framework for targeted treatments to match specific concussion 
profiles and recovery trajectories. It is important to note that although clinical profiles are 
both intuitive and supported anecdotally, to date they have not been empirically validated. 
As such, more research and clinical evidence are required to examine current and emerging 
concussion clinical profiles to further refine this targeted, active treatment approach.
9 Thorough multi-domain assessment is warranted to properly evaluate the 
clinical profiles of concussion.
Concussion is a complex, heterogeneous injury that presents with a variety of functional 
deficits and clinical findings, which warrant a thorough evaluation to appropriately assess 
the injury and treat the injury. Both the acute assessment of a potential concussion and 
subsequent evaluations should involve a systematic, careful examination. The primary goal 
of the acute evaluation is to determine whether a concussion has occurred and implement 
immediate steps for care. The goals of the sub-acute evaluation are to characterize the 
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clinical presentation and profiles of the injury, including multi-domain levels of functioning, 
and prescribe an individualized treatment plan.17,21,23,114,115,120
Although clinical presentations are highly variable, certain clinical profiles are often 
identifiable via the use of a multi-domain assessment, which may include:
• Review of mechanism of injury, specifically location, force, and direction 
of trauma17,21,23,114,115,120
• Relevant past medical history including age, gender, prior concussion 
history, and comorbid “concussion risk factors”77,95,102,121
• Symptom identification using symptom checklists17,21,23,114,115,120
• Neurocognitive screening or neuropsychological 
evaluation61,75,76,93,102,122–126
• Balance assessment58,123,127,128
• Vestibular screening or examination85,115,129
• Assessment or screening of ocular motor function115,129–131
• Neurological exam17,21,23,114,115,120
• Examination of the cervical spine114,120,132
• Consideration of neuroimaging if indicated133–135
• Evaluation of psychological factors associated with concussion17,136,137
It is important to recognize that the list above is not exhaustive and each of the above 
components represent 1 aspect of a comprehensive concussion evaluation approach and 
should not be used in a stand-alone manner. Taken together, the evaluation of each of these 
components provides a thorough, multi-domain assessment. This approach allows clinicians 
to better define the injury, thereby providing appropriate direction and education regarding 
recovery expectations, rehabilitation measures, treatment options, and potential prescriptive 
therapeutic interventions.
10 A multidisciplinary treatment team offers the most comprehensive approach to 
treating the clinical profiles associated with concussion.
The heterogeneous presentation and clinical profiles of concussion may require access to an 
array of healthcare specialists from multiple disciplines to help design and execute targeted 
treatment plans, and educate individuals and their families. The formation of 
multidisciplinary approaches to concussion care and healthcare provider networks may 
result in improved standardization of care, decreased resource utilization, and better ensure 
the provision of services for concussion.138–140 At the core of the multidisciplinary team is 
the coordinating healthcare provider, typically a physician (ie, neurologist, neurosurgeon, 
primary care/sports medicine physician, emergency medicine physician, physical medicine 
and rehabilitation physician) or clinical neuropsychologist.139 In addition, other healthcare 
specialties may be involved in specific aspects of the care for patients with concussion 
including the physical or vestibular therapist, athletic trainer, optometrist or ophthalmologist, 
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speech and language pathologist, clinical or sport psychology professional, or occupational 
therapist). Lastly, it is important to note that the creation of multi-disciplinary teams may 
vary based on the resources locally available. For example, in rural areas individuals from 
multiple specialties may not be readily accessible, which may necessitate the development 
of consultative relationships and emerging technologies including telehealth.
Targeted Evaluation and Active Management Approach to Concussion: Specific Strategies
11 Concussion is treatable.
Although there are no recognized treatments for the underlying pathophysiology of 
concussion, there is agreement among experts that the clinical spectrum of concussion 
symptoms and impairments are treatable.141 There is already published empirical evidence 
that concussion is treatable through active approaches involving earlier activity,35 aerobic 
exertion,142 vestibular,85,132 and vision143 therapies. Overall, these studies demonstrate that 
active treatments are more effective than rest-based approaches.
A major focus of current clinical efforts that involves associating a comprehensive 
examination of the symptoms, impairments, and clinical profiles of concussion may lead to 
the identification of targeted treatment pathways that may expedite recovery.16,114,138 The 
treatment of concussion symptoms and impairments is evolving. Past practice of prolonged 
rest (see DiFazio et al, 2016)50 has advanced to current hypotheses on the benefits of more 
active approaches to rehabilitation including vestibular,132,144 oculomotor/vision,143,145 and 
behavioral146 therapies. Active rehabilitation involves an interdisciplinary approach directed 
at addressing and treating the specific, individual symptoms, impairments, and clinical 
profiles that may be identified at clinical presentation.
The role of active rehabilitation and treatment strategies in changing the underlying 
concussion pathophysiology and concomitant recovery process in the brain needs further 
study. A detailed history and clinical examination together with a multidimensional 
assessment of patients with concussion may help identify distinct clinical profiles that can 
guide treatment and potentially improve the trajectory of recovery (see number 9).114,138 As 
with other diseases and injuries, there are many treatments that are directed at alleviating the 
signs and symptoms while the underlying disease or injury process runs its course (eg, 
common cold, minor sprains). However, those same treatments may not alter/treat the 
underlying disease or injury process. Similarly, treatments for concussion are directed at 
symptoms and impairments and are vital to current individualized concussion management.
The current consensus is that evidence-based treatments for the underlying pathophysiology 
of concussion are lacking. Moreover, until more data are available, healthcare providers 
should be mindful of over-utilizing or advertising unproven treatments that lack empirical 
support and validation, and that may lead to complications. Additional evidence-based 
research is needed to better determine the mechanism and effectiveness of targeted active 
interventions on the underlying pathophysiology of concussion. Nonetheless, emerging 
evidence indicates that active treatment of concussion is effective for some patients.
12 Preliminary evidence suggests that active rehabilitation may improve symptom 
recovery more than prescribed rest alone after concussion.
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13 Active treatment strategies may be initiated early in recovery following 
concussion.
Active treatment with a patient can be initiated on the day of the injury. Three studies 
provide evidence for the effectiveness of concussion education in the Emergency 
Department on managing injury expectations in adults147 and children.148,149 Patients and 
families who received explicit discharge education and management strategies related to 
their symptoms exhibited more positive recovery outcomes than control participants. There 
is limited empirical evidence for the presumed relationship of prescribed physical and 
cognitive rest to a subsequent decrease in symptoms and cognitive impairment.33 As such, 
more active approaches to treating concussion may be effective for certain patients (see 
number 4). Findings from animal studies demonstrate that an “enriched environment” of 
physical and cognitive stimulation enhances histologic, cognitive, and behavioral recovery 
from TBI.150–152 An enriched environment consists of opportunities to participate in 
physical activities, social networks, and intellectual activities, most of which are restricted 
when rest is prescribed for patients. In contrast, impoverished environments, particularly 
during brain maturation, are reported to stunt synaptic plasticity and cognitive 
development.153,154
Emerging empirical research suggests that exposing patients with persistent post-concussive 
injury to supervised low level physical activity is not only safe153 but effective.13,31,155–159 
Brief submaximal (60% submaximal capacity) aerobic training, sport-specific light 
coordination activity, vestibular therapy, treadmill exercise, visualization, and home 
exercises have been utilized safely as exertional activity in patents with persistent 
concussion symptoms.155–157 The report of the Institute of Medicine of the National 
Academies on concussion in sport stated, “there is little evidence regarding the efficacy of 
rest following concussion or to inform the best timing and approach for return to activity…” 
and recommended RCTs to determine the efficacy of physical/cognitive rest.160 Although 
the specifics of timing and exertion type have yet to be determined empirically, it is the 
agreed opinion of the authors that preliminary clinical evidence suggests that supervised 
individually tailored active physical and cognitive rehabilitation may improve symptom 
recovery more than prescribed rest alone after concussion, and that active treatment 
strategies may be initiated early during recovery from concussion. Regardless of this 
opinion, additional RCTs are warranted to compare the benefits of prescribed physical rest 
to more physically active (ie, physical exertion) treatments.
14 Matching targeted and active treatments to clinical profiles may improve 
recovery trajectories following concussion.
Although there are no clear evidence-based treatments for concussion, emerging clinical 
research and observations suggest that recovery after concussion may be facilitated when 
targeted, active interventions are matched to the patient’s clinical profile based on 
presentation and history.16,114,115,138 For example, patients that present with post-
concussion vestibular impairment and symptoms (eg, dizziness, vertigo, impaired balance, 
visual motion sensitivity) may benefit from vestibular rehabilitation exercises that treat 
benign paroxysmal positional vertigo (BPPV) and improve balance, gaze stability, eye-head 
coordination and gait.144 Similarly, the efficacy of vision therapy was recently reported to be 
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beneficial for patients with concussion and mild TBI that exhibited common oculomotor 
issues such as reading difficulty, vergence, accommodation, saccade, or pursuit 
impairment.143,145 Vision therapy (orthoptics), employs a variety of vision exercises and 
tools designed to improve oculomotor control, focusing, coordination, and teaming. In 
addition to vestibular rehabilitation and vision therapy, exercise prescribed as an adjunct to 
other therapies or medication may reduce symptoms of depression and anxiety,161,162 and 
may prevent or modify the intensity of migraines that often accompany 
concussion.11,103,163–165 As another example, patients who are slow to recover after 
concussion may benefit from the addition of exertion training programs.155156,166 Patients 
experiencing psychological and behavioral effects following concussion such as 
anxiety96,167 and depression11,167,169 may benefit from cognitive behavioral therapy (CBT) 
and other psychotherapeutic and behavioral interventions.121 Finally, cervical dysfunction 
and cervicogenic headaches occurring after concussion may be managed with manual 
therapy to the cervical spine and head/neck proprioceptive re-training.115,132
No single treatment strategy will be effective for all patients following concussion due to the 
individualized nature of the injury and its clinical consequences. Multiple active 
rehabilitation strategies are now available with growing evidentiary basis for efficacy when 
matched to specific symptoms and impairments.
15 Patients returning to school/work while recovering from concussion benefit 
from individualized management strategies
Following concussion, the active return to school and work is a major priority for the 
recovering patient.26 Appropriate individualized supports must be in place to facilitate 
recovery for the symptomatic student/employee.170 To support this return, symptom and 
clinical profile-targeted accommodative supports and adjustments may be necessary to 
balance the goals of recovery and return to productivity. For example, in patients with 
vestibular dysfunction, modifications in the school environment to lessen the triggers for 
their symptoms, such as removal from gym or dance class, band/orchestra, or school 
assemblies may be employed. Injured students with oculomotor dysfunction may require 
delaying their tests/quizzes and reducing the amount of homework during the initial 
recovery period. Support should be individualized based on clinical presentation, symptoms 
and impairment, patient history, and assessment results. It is important to support the 
recovering student, but also ensure that modifications are not prolonged when no longer 
necessary or do not provide an unfair advantage to the injured student. These issues can be 
determined by serial multi-domain assessment and monitoring of the patient’s status.
Presently, no multisite clinical trials have been conducted to validate which specific 
treatments, their timing or duration will facilitate successful return to school and work. 
Although clinical recommendations provide clinicians and school personnel with practical 
and logical suggestions, their application requires further research to demonstrate optimal 
benefit and avoid excessive or unnecessary use. The underlying premise to these 
interventions is that active, progressive school-based management with concussion clinical 
profile-targeted recommendations may mitigate adverse effects on school learning and work 
productivity, reduce patient concerns on the impact of the injury on performance, and lower 
the risk of prolonged recovery. In the school context, Gioia advocates for explicit training of 
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medical and school systems to facilitate the student’s individualized program of gradual 
return, identifying key symptom targets tied to accommodation strategies, monitoring 
progress, and applying systematic criteria for progression to the next less restrictive level of 
support.170 Prolonged absence from one’s school or work environment must be avoided to 
reduce the risk of secondary adverse social and emotional effects (eg, anxiety) from 
disengagement and lack of involvement in previously enjoyed activities. To inform 
treatment-relevant targets, Ransom et al171 provide initial evidence for the impact of 
concussion on academic learning and performance (eg, headaches and fatigue interfering 
with learning, greater difficulty understanding new material).
Several clinically-based support systems are available to guide symptom-targeted school 
interventions including the CDC’s “Heads Up to Schools: Know Your Concussion 
ABC’s”;172 Colorado’s Remove/Reduce, Educate, Adjust/Accommodate, Pace (REAP) 
program;173 BrainSTEPS;174 and The Brain 101 Schoolwide Concussion Management 
program.146 The Brain 101 program was first implemented through a randomized controlled 
trial. The program incorporates skills training, guidelines on creating a concussion 
management team, and symptom-targeted strategies for supporting students in the 
classroom. Students in the Brain 101 intervention group received more individualized/
customized academic accommodations than students in control schools. This study 
demonstrated significant increases in sports concussion knowledge, knowledge of academic 
management strategies, and plans to implement these concussion management strategies.146 
Additional evidence from a multisite pediatric concussion education program in the 
Emergency Department demonstrated that early education via focused concussion discharge 
instructions and a Return to School letter increased implementation of academic supports at 
school.149 Evidence-based systematic protocols for return to work following concussion do 
not currently exist, although clinical recommendations for returning employees are provided 
on the ACE Care Plan-Work version in the CDC Heads Up to Healthcare Providers175 
including schedule considerations (eg, shortened work day, more frequent breaks) and safety 
considerations (eg, not lifting heavy loads, operating risky machinery). Continued 
investigation of effective, targeted interventions based on symptoms and impairment for 
return to school and work via multi-site RCTs is warranted.
16 Pharmacological therapy may be indicated in selected circumstances to treat 
certain symptoms and impairments related to concussion.
There is little randomized-controlled data on the effectiveness of pharmacological therapies 
in patients with concussion. Nonetheless, in the collective clinical experience of the authors 
with a wide variety of concussion patients over many years, optimal treatment can be 
obtained using a combination of 3 elements: a) active treatment and rehabilitation, b) 
lifestyle management, and c) pharmacological therapies; Pharmacological therapies should 
target specific symptoms and impairments. For example, cognitive deficits might be treated 
using direct or indirect stimulants, whereas, migraine symptoms might be treated using 
triptans. We should note that a blanket approach to treating all patients with a concussion 
using the same pharmacological therapy is contraindicated and should be avoided. Although 
there is limited empirical evidence for pharmacological therapies (eg, for amantadine113), 
many of these approaches are discussed in recent reviews6,16 and concussion care guides. 
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We encourage the reader to review these guides for more specific recommendations 
regarding pharmacological therapies. The timing of pharmacological therapies may be 
influenced by pre-existing conditions. For example, a patient with a history consistent with 
migraine headaches may benefit from earlier administration of a migraine prophylactic 
medication. Similarly, a patient with a history consistent with depression may benefit from 
earlier administration of an antidepressant. Additionally, patients already on such 
medications may benefit from a temporary increase in their medication. Conversely, 
decreasing or discontinuing a patient’s medication in the setting of concussion may 
exacerbate symptoms. However, it is also important to avoid certain pharmacological 
therapies that can, based on our collective clinical experience, worsen overall recovery 
following concussion. In general, it is recommended that clinicians avoid the following: 1) 
routine-defined as more than 3 days per week for 2 weeks or more-use of narcotics, 
butalbital preparations, and pain medication; 2) neuroleptics, excess alcohol, 
benzodiazepines, and anticholinergics such as diphenhydramine as routine treatments for 
insomnia; 3) leviteracetam in patients with mood instability; and 4) sedating medications in 
patients with severe fatigue and hypersomnia. In conclusion, collective clinical experience 
indicates that judicious pharmacological therapies can in many cases provide symptomatic 
benefit following concussion. However, the lack of empirical data to support specific 
prescription guidelines for the use of pharmacological therapies for patients, concussion 
highlights the need for additional research in this area.
Future Directions: A Call to Research
An important objective of this paper and the preceding meeting was to provide suggestions 
for researchers and clinicians to consider as next steps to build on the statements of 
agreement above. To that end, the future directions statements of agreement in Table 3 were 
developed and supported. We also believe that in order to capitalize on the momentum of 
this paper sport, military, and public health organizations should act on the future directions 
in Table 3 by directing funding to expand our understanding of the symptoms and 
impairments for concussion clinical profiles, biomarkers to assess injury and recovery, and 
the effectiveness of targeted, active treatments. It is important to note that although it was 
outside of the scope of the current paper and meeting, we believe that there is a need for 
further research on biomarkers (eg, neuroimaging, blood) to assess concussion and the 
effectiveness of any proposed treatments.
CONCLUSION
Recent evidence challenges the prevailing notion that management of concussion should be 
based primarily on prescribed cognitive and physical rest. Furthermore, a uniform approach 
involving prescribed rest may not be effective for all patients; strict brain rest is 
contraindicated and may exacerbate the effects of this injury. Surprisingly, there has been 
limited focus in the literature and previous consensus meetings on active approaches to 
treating concussion. Concussions are characterized by diverse symptoms and impairments 
and recovery from this injury may vary depending on modifying factors, injury severity, and 
treatments. Emerging concussion clinical profiles determined via a comprehensive multi-
domain assessment may help inform more targeted approaches to treating this injury. 
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Concussion symptoms and impairments are treatable and active rehabilitations involving a 
multidisciplinary treatment team may enhance recovery. Matching treatments to specific 
symptoms, impairments, and clinical profiles may also improve recovery following 
concussion. Return to school/work following concussion presents a unique challenge to 
clinicians that can be enhanced using an individualized approach. In certain instances, the 
judicious application of pharmacotherapies may be effective for patients with certain clinical 
profiles. Additional research is needed to validate concussion clinical profiles, identify 
biomarkers to assess the effectiveness of treatments, and determine the best timing of 
specific concussion treatments.
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EXECUTIVE SUMMARY
Purpose of the Statement
• To challenge common misconceptions about treating concussion.
• To review the current state of treatment for concussion.
• To describe and discuss interdisciplinary, targeted evaluation and active 
management approaches for treating concussion.
• To describe empirical gaps in existing research related to the treatment 
and rehabilitation of concussion.
• To identify areas requiring further research.
Importance of the Statement
• Many clinicians and the public do not recognize that concussions are a 
treatable injury.
• Evidence-based guidance on effective treatments for concussion is 
lacking, making it difficult for clinicians to determine how best to treat 
patients with this injury.
• Clinicians from a variety of healthcare disciplines and with various 
degrees and backgrounds commonly treat patients with concussions.
• Conventional treatment for concussion focuses on an approach 
involving prescribed rest and progressive return to activity.
• In spite of general perceptions to the contrary, although exertion may 
occasionally exacerbate symptoms following concussion, it is unlikely 
to cause additional brain damage/injury.
• Concussions are individualized injuries characterized by diverse and 
variable physical, cognitive, emotional, and sleep-related symptoms 
and impairment.
• Patient-centered treatments for concussion involving active approaches 
may benefit recovery for certain patients.
• This statement may be useful in guiding the treatment of concussions 
that result from sport and recreational activities, motor vehicle 
collisions, falls, assaults, and those occurring during military service.
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KEY POINTS OF AGREEMENT
Summary of the Current Approach to Treating Concussion
1 Prior expert consensus for management of concussion included: a) no same-
day return to play (RTP), b) prescribed physical and cognitive rest until 
asymptomatic, c) accommodations at school/work as needed, and d) 
progressive aerobic exertion-based RTP based on symptoms.
2 Previous consensus statements have provided limited guidance with regard 
to the active treatment of concussion.
3 There is limited empirical evidence for the effectiveness of prescribed 
physical and cognitive rest, and no multi-site randomized controlled trial 
(RCT) for prescribed rest following concussion.
4 Prescribed physical and cognitive rest may not be an effective strategy for 
all patients following concussion.
5 Strict brain rest (eg, stimulus deprivation, “cocoon” therapy) is not indicated 
and may have detrimental effects on patients following concussion.
6 Although most individuals follow a rapid course of recovery over several 
days to weeks following injury, concussions may involve varying lengths of 
recovery.
7 Recovery from concussion is influenced by modifying factors, the severity 
of injury, and the type and timing of treatment that is applied.
Heterogeneity and Evolving Clinical Profiles of Concussion
8 Concussions are characterized by diverse symptoms and impairments in 
function resulting in different clinical profiles and recovery trajectories.
9 Thorough multi-domain assessment is warranted to properly evaluate the 
clinical profiles of concussion.
10 A multidisciplinary treatment team offers the most comprehensive approach 
to treating the clinical profiles associated with concussion.
Targeted Evaluation and Active Management Approach to Concussion: Specific 
Strategies
11 Concussion is treatable.
12 Preliminary evidence suggests that active rehabilitation may improve 
symptom recovery more than prescribed rest alone after concussion.
13 Active treatment strategies may be initiated early in recovery following 
concussion.
14 Matching targeted and active treatments to clinical profiles may improve 
recovery trajectories following concussion.
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15 Patients returning to school/work while recovering from concussion benefit 
from individualized management strategies.
16 Pharmacological therapy may be indicated in selected circumstances to treat 
certain symptoms and impairments related to concussion.
Future Directions: A Call to Research
• There is growing empirical support for the heterogeneity of this injury 
and clinical profiles but additional research in these areas is warranted.
• The clinical benefits (eg, more rapid recovery time, more complete 
restoration of function, reduced risk of repeat injury, etc.) of prescribed 
active interventions require further study, ideally through RCTs.
• Complementary and integrative therapies for concussion require 
additional research.
• The role of modifying factors on the effectiveness of treatments 
warrants further investigation.
• Multisite, prospective studies of concussion treatments across various 
post-injury time points are needed.
• There is a need and a role for empirically- and clinically-based 
treatment and rehabilitation approaches, as we await validation through 
prospective studies.
• There is a need for further research on biomarkers (eg, neuroimaging, 
blood) to assess concussion and the effectiveness of any proposed 
treatments.
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